Table 4.
Other diagnoses in individuals with GAD for all sites that were included in the main analysis.
| Site | SAD | PD | AG | SPH | Other ANXD | MDD | OCD | PTSD | SUD | OtherD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cur | LT | Cur | LT | Cur | LT | Cur | LT | Cur | LT | Cur | LT | Cur | LT | Cur | LT | Cur | LT | Cur | LT | |
| ABCD | 4 | 16 | 0 | 3 | 0 | 1 | 21 | 30 | 4 | 45 | 3 | 10 | 18 | 5 | 0 | 8 | 1 | 0 | 61 | 28 |
| Barcelona | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Baylor | 26 | 0 | 3 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 62 | 1 | 5 | 3 | 14 | 2 | 50 | 7 | 80 | 1 |
| BHRCS | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | NA | NA | 5 | 0 |
| Boystown | 30 | 0 | NA | NA | NA | NA | NA | NA | 0 | 0 | 19 | 0 | NA | NA | 16 | 0 | NA | NA | 0 | 0 |
| Chicago-Milad | 5 | 0 | 5 | 0 | 2 | 0 | 6 | 0 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Chicago-Phan | 50 | 0 | 21 | 0 | 6 | 0 | 14 | 0 | 0 | 0 | 42 | 1 | 2 | 0 | 14 | 2 | 1 | 0 | 3 | 0 |
| CMI-HBN | 9 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 5 | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | NA | NA |
| Dresden | 6 | 0 | 7 | 3 | 7 | 1 | 11 | 0 | 2 | 1 | 12 | 6 | 0 | 0 | 0 | 2 | 0 | 0 | 13 | 5 |
| Duke | 1 | 1 | NA | NA | NA | NA | NA | NA | 2 | 1 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Harvard | 75 | 2 | 17 | 12 | 14 | 3 | 25 | 2 | NA | NA | 29 | 64 | 14 | 4 | 10 | 6 | 0 | 5 | 13 | 8 |
| IOL | 6 | NA | 2 | NA | 1 | NA | 0 | NA | 0 | NA | 9 | NA | 0 | NA | 0 | NA | 0 | NA | 2 | NA |
| Milan | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 |
| Muenster | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Pittsburgh- Andreescu | 2 | 0 | 4 | 1 | 0 | 0 | 0 | 0 | NA | NA | 0 | 5 | 0 | 0 | 1 | 0 | 1 | 0 | 2 | 4 |
| SHIP | 0 (1 NA) | 3 (1 NA) | 0 | 2 | 0 | 1 | 0 | 4 | 0 | 0 | 0 (2 NA) | 8 (2 NA) | 0 (2 NA) | 0 (2 NA) | 0 | 0 | 0 (1 NA) | 4 (1 NA) | 0 | 0 |
| SDAN | 80 | 12 | 2 | 0 | 0 | 0 | 46 | 0 | 0 (23 NA) | 0 (23 NA) | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 6 (23 NA) | 1 (23 NA) |
| StonyBrook | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sussex | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| UCSD | 20 | 4 | 4 | 2 | 4 | 0 | NA | NA | 0 | 0 | 8 | 8 | 2 | 0 | 0 (14 NA) | 2 (14 NA) | 0 | 3 | 0 | 0 |
| UPenn | 0 | 4 | 0 | 1 | 0 | 1 | 0 | 5 | 0 | 4 | 0 | 7 | 0 | 2 | 0 | 4 | NA | NA | 0 | 8 |
| WashU | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 6 |
| Total | 327 | 42 | 65 | 31 | 36 | 8 | 133 | 43 | 19 | 57 | 227 | 122 | 41 | 14 | 55 | 26 | 56 | 20 | 189 | 64 |
SAD social anxiety disorder, PD panic disorder, AG agoraphobia, SPH specific phobia, Other ANXD other anxiety disorder, MDD major depressive disorder, OCD obsessive-compulsive disorder, PTSD post-traumatic stress disorder, SUD substance use dependence, OtherD other disorder, Cur current, LT lifetime, NA not available, ABCD Adolescent Brain Cognitive Development Study, BHRCS Brazilian High Risk Cohort Study, CMI-HBN Child Mind Institute Healthy Brain Network, IOL Institute of Living, SDAN Section on Development and Affective Neuroscience, SHIP Study of Health in Pomerania, UCSD University of California – San Diego, UPenn University of Pennsylvania, WashU Washington University.